Archford Capital Strategies LLC Has $1.28 Million Stock Position in Amdocs Limited $DOX

Archford Capital Strategies LLC reduced its position in Amdocs Limited (NASDAQ:DOX) by 47.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,951 shares of the technology company’s stock after selling 14,678 shares during the period. Archford Capital Strategies LLC’s holdings in Amdocs were worth $1,284,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC lifted its position in Amdocs by 0.6% in the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock worth $540,976,000 after buying an additional 42,184 shares in the last quarter. LSV Asset Management grew its position in Amdocs by 7.6% in the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock worth $299,376,000 after acquiring an additional 257,193 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Amdocs by 1.8% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after purchasing an additional 54,676 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Amdocs by 3.0% in the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after acquiring an additional 91,900 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in Amdocs by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after buying an additional 9,207 shares during the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Barclays decreased their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, February 4th. Stifel Nicolaus cut their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Amdocs has an average rating of “Moderate Buy” and an average target price of $92.33.

Amdocs Stock Performance

NASDAQ:DOX opened at $65.26 on Wednesday. The firm has a market capitalization of $7.04 billion, a PE ratio of 12.62, a price-to-earnings-growth ratio of 1.15 and a beta of 0.42. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 12-month low of $63.33 and a 12-month high of $95.41. The firm has a 50-day moving average price of $70.74 and a 200 day moving average price of $77.44.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. The company had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Research analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be given a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 3.5%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is presently 43.91%.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.